 The Heart Protection Study established the protective effects of statin therapy in reducing
mortality and cardiovascular events among individuals with
PAD.56 However, asymptomatic PAD patients were not
speciÔ¨Åcally included unless they met other criteria, such as
diabetes, hypertension, or other history of clinical cardiovascular or cerebrovascular disease. In addition to reducing
cardiovascular event rates, statin use has been associated with
improved lower extremity functioning.57 This improvement
